The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 698K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

13 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Specificity and inhibitory mechanism of andrographolide and its analogues as antiasthma agents on NF-¿B p50.EBI
National University of Singapore
Psoralen derivatives as inhibitors of NF-¿B/DNA interaction: synthesis, molecular modeling, 3D-QSAR, and biological evaluation.EBI
University of Padova
Cytotoxic and NF-kappaB inhibitory constituents of Artocarpus rigida.EBI
The Ohio State University
Virtual screening against nuclear factor¿B (NF-¿B) of a focus library: Identification of bioactive furocoumarin derivatives inhibiting NF-¿B dependent biological functions involved in cystic fibrosis.EBI
Biopharmanet
Cytotoxic xanthone constituents of the stem bark of Garcinia mangostana (mangosteen).EBI
The Ohio State University
A new small molecule that directly inhibits the DNA binding of NF-kappaB.EBI
Tokushima Bunri University
Gibberellin JRA-003: A Selective Inhibitor of Nuclear Translocation of IKKα.EBI
University of Michigan
2-Chloro-4-(trifluoromethyl)pyrimidine-5-N-(3',5'- bis(trifluoromethyl)phenyl)-carboxamide: a potent inhibitor of NF-kappa B- and AP-1-mediated gene expression identified using solution-phase combinatorial chemistry.EBI
Signal Pharmaceuticals
Compounds for the treatment of kinase-dependent disordersBDB
Exelixis
Indazolyl-spiro[2.3]hexane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereofBDB
Merck Sharp & Dohme
Cyanopyrrolidines as dub inhibitors for the treatment of cancerBDB
Mission Therapeutics
Inhibition studies of soybean (Glycine max) urease with heavy metals, sodium salts of mineral acids, boric acid, and boronic acids.BDB
Banaras Hindu University
Characterization of a novel bivalent morphinan possessing kappa agonist and micro agonist/antagonist properties.BDB
University of Rochester